Verdence Capital Advisors LLC Atai Life Sciences N.V. Transaction History
Verdence Capital Advisors LLC
- $1.66 Billion
- Q3 2025
A detailed history of Verdence Capital Advisors LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 19,178 shares of ATAI stock, worth $76,712. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,178
Previous 19,178
-0.0%
Holding current value
$76,712
Previous $41,000
146.34%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
148Shares Held
45.9MCall Options Held
1.88MPut Options Held
543K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$21.7 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.15 Million12.47% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...